Announce Date | 08/12/2025 |
EPS Normalized Actual | $0.16 (Beat by $0.03) |
EPS GAAP Actual | $0.16 (Beat by $0.03) |
Revenue Actual | $0.280615B |
Revenue Surprise | Beat by $280.615M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 1.975 | 32.05 | 1.82335 | 2.11208 | 1 |
Dec 2029 | 1.67935 | 37.69 | 1.52234 | 1.75261 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ3 2025 (Jul 2025) | 0.16 | 0.16 | 0.280615B | 16.79% | 280.62M |
FQ2 2025 (Apr 2025) | 0.22 | 0.22 | 0.331826B | 100% | 331.83M |
FQ4 2024 (Oct 2024) | 0.16 | 0.16 | 0.243817B | 27.33% | 243.82M |
FQ3 2024 (Jul 2024) | 0.17 | 0.17 | 0.233495B | 24.82% | 233.5M |
FQ3 2022 (Jul 2022) | -0.0725 | -0.0725 | 0.135915B | 100% | 135.92M |
FQ1 2024 (Mar 2024) | 0.89 | 0.89 | 0.3338B | 100% | 333.8M |
FQ4 2023 (Dec 2023) | 0.0175 | 0.0175 | 0.17717B | 100% | 177.17M |
FQ2 2023 (Jun 2023) | 0.23 | 0.23 | 0.172894B | 100% | 172.89M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2029 (Jul 2029) | 0 | -- | 0 | 0 | 3 |
FQ2 2029 (Apr 2029) | 0 | -- | 0 | 0 | 4 |
FQ1 2029 (Jan 2029) | 0 | -- | 0 | 0 | 3 |
FQ4 2028 (Oct 2028) | 0 | -- | 0 | 0 | 5 |
FQ3 2028 (Jul 2028) | 0 | -- | 0 | 0 | 4 |
FQ2 2028 (Apr 2028) | 0 | -- | 0 | 0 | 5 |
FQ1 2028 (Jan 2028) | 0.16716 | -- | 0.16413 | 0.17266 | 4 |
FQ4 2027 (Oct 2027) | 0.17366 | -- | 0.17052 | 0.17938 | 4 |
FQ3 2027 (Jul 2027) | 0.14386 | -- | 0.14125 | 0.1486 | 3 |
FQ2 2027 (Apr 2027) | 0.27629 | -- | 0.257 | 0.28572 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2029 (Jul 2029) | 0.54B | -- | 0.53B | 0.55B | 5 |
FQ2 2029 (Apr 2029) | 0.59B | -- | 0.58B | 0.6B | 5 |
FQ1 2029 (Jan 2029) | 0.58B | -- | 0.57B | 0.59B | 5 |
FQ4 2028 (Oct 2028) | 0.69B | -- | 0.68B | 0.71B | 4 |
FQ3 2028 (Jul 2028) | 0.46B | -- | 0.46B | 0.47B | 4 |
FQ2 2028 (Apr 2028) | 0.5B | -- | 0.49B | 0.51B | 4 |
FQ1 2028 (Jan 2028) | 0.41B | -- | 0.4B | 0.42B | 4 |
FQ4 2027 (Oct 2027) | 0.41B | -- | 0.4B | 0.42B | 5 |
FQ3 2027 (Jul 2027) | 0.4B | -- | 0.39B | 0.41B | 5 |
FQ2 2027 (Apr 2027) | 0.43B | -- | 0.4B | 0.44B | 8 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2025 (Jul 2025) | 0.16 | 0.16 | 100% | |
FQ2 2025 (Apr 2025) | 0.22 | 0.22 | 100% | |
FQ4 2024 (Oct 2024) | 0.16 | 0.16 | 100% | |
FQ3 2024 (Jul 2024) | 0.17 | 0.17 | 100% | |
FQ3 2022 (Jul 2022) | -0.0725 | -0.0725 | 100% | |
FQ1 2024 (Mar 2024) | 0.89 | 0.89 | 100% | |
FQ4 2023 (Dec 2023) | 0.0175 | 0.0175 | 100% | |
FQ2 2023 (Jun 2023) | 0.23 | 0.23 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2025 (Jul 2025) | $0B | $0.28B | $280.62M | 100% |
FQ2 2025 (Apr 2025) | $0B | $0.33B | $331.83M | 100% |
FQ4 2024 (Oct 2024) | $0B | $0.24B | $243.82M | 100% |
FQ3 2024 (Jul 2024) | $0B | $0.23B | $233.5M | 100% |
FQ3 2022 (Jul 2022) | $0B | $0.14B | $135.92M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.33B | $333.8M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.18B | $177.17M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.17B | $172.89M | 100% |